April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Could Loss of Calpastatin Lead to Activation of Calpains in Human Lenses?
Author Affiliations & Notes
  • Takeshi Nakajima
    Senju Laboratory of Ocular Sciences, Senju Pharmaceutical Co Ltd, Kobe, Japan
  • Thomas R. Shearer
    Department of Integrative Biosciences, Oregon Health & Sciences University, Portland, Oregon
  • Mitsuyoshi Azuma
    Department of Integrative Biosciences, Oregon Health & Sciences University, Portland, Oregon
    Senju Laboratory of Ocular Sciences, Senju Pharmaceutical Co Ltd, Portland, Oregon
  • Footnotes
    Commercial Relationships  Takeshi Nakajima, Senju Pharmaceutical Co Ltd (E); Thomas R. Shearer, Senju Pharmaceutical Co Ltd (C); Mitsuyoshi Azuma, Senju Pharmaceutical Co Ltd (E)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 1531. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Takeshi Nakajima, Thomas R. Shearer, Mitsuyoshi Azuma; Could Loss of Calpastatin Lead to Activation of Calpains in Human Lenses?. Invest. Ophthalmol. Vis. Sci. 2011;52(14):1531.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Calpains are calcium-activated, intracellular, nonlysosomal, cysteine proteases. Activation of calpains (CAPN2 and Lp82) in rodent lenses readily causes proteolysis and cataract formation. In contrast, primate lenses are quite resistant to activation of calpain, presumably because of the high levels of endogenous calpain inhibitor, calpastatin (CS). Loss of CS activity during aging, such as in Alzheimer's disease, is under investigation. Thus, purpose of present study was to examine the consequences of knock down of CS in a human lens epithelial cell line, HLE-B3.

Methods: : Transcripts for CS and calpains were measured by qPCR. Small interference RNAs (siRNAs) were used to reduce the expression of calpastatin in HLE-B3 cells, which were then cultured with the calcium ionophore ionomycin, with or without calpain inhibitor SNJ1945. Calpain activity in cells was detected by immunoblotting for the calpain-specific, α-spectrin breakdown product at 145 kDa and for activation-associated, fragments of calpain. Release of LDH into the culture medium was measured as a marker for cell death.

Results: : Without CS knockdown, proteolysis of α-spectrin was observed in soluble proteins from αTN-4 cells (mouse comparator cell line) incubated with calcium, but not in the human HLE-B3 cells. Expression of CS in HLE-B3 cells was higher than αTN-4 cells. Transfection of CS siRNA into HLE-B3 cells reduced expression of CS mRNA and protein. When the CS siRNA-transfected-HLE-B3 cells were cultured with ionomycin; calpains were activated, specific proteolysis of α-spectrin was observed, and cell death ensued. Calpain inhibitor SNJ1945 inhibited these changes.

Conclusions: : Our data demonstrate that the high level of endogenous CS normally fully inhibits calpains in human lens epithelial cells. Our hypothesis is that aging of human lens epithelial cells causes loss of CS activity; allowing activation of long-dormant calpains, proteolysis of critical cytoskeletal proteins, and cataract formation.

Keywords: calcium • apoptosis/cell death • cataract 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×